Nature Structural & Molecular BiologyGenomicsPeer-reviewed journal article
Spacer Extension Reconciles Specificity and Activity in High-Fidelity Cas9 Genome Editing
Rong Zheng, Zhike LuiD, Rongwei Wei, Young-Cheul ShiniD, Jiang DuiD, Qingfeng Zhang, Jianbo LiiD, Xiaoqi Wang, Yi WeiiD, Botao LiuiD, Yang Chen, Lihong DingiD, Heng ZhangiD, Hui CheniD, Jing HuangiD, Lijia MaiD
Abstract
AbstractEngineering high-fidelity CRISPR enzymes often leads to reduced cleavage activity, creating a significant hurdle in balancing nuclease specificity and efficiency for clinical applications. Here, we demonstrate that extending the spacer to 21 or 22 nucleotides restores the impaired cleavage activity of SuperFi-Cas9, an engineered high-fidelity Cas9 variant with seven mutations at the PAM-distal region. Structural and mutational analyses reveal that the spacer extension strengthens additional interactions at the PAM-distal end, stabilizing the nuclease- sgRNA-DNA complex, which appears to be disturbed due to the seven mutations. This approach not only provides a high-fidelity Cas9 with uncompromised efficiency but also introduces a novel strategy to enhance CRISPR complex stability. Our findings offer a promising avenue for precise and efficient genome editing, crucial for advancing CRISPR technologies toward clinical translation.
- assay: CRISPR screen
- research focus: protein design
- research focus: variant effect prediction
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 4
- FWCI
- 8.21
- Field percentile
- top 2%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- SuperFi-Cas9 exhibits extremely high fidelity but reduced activity in mammalian cells
Péter István Kulcsár, András Tálas, … Ervin Welker·Nature CommunicationsPeer-reviewed·Nov 11, 2022
- Enhanced proofreading governs CRISPR-Cas9 targeting accuracy
J. S. Chen, Y. S. Dagdas, … J. A. Doudna·bioRxiv·Aug 12, 2017
- Crossing enhanced and high fidelity SpCas9 nucleases to optimize specificity and cleavage
P. I. Kulcsar, A. Talas, … E. Welker·bioRxiv·Sep 12, 2017
- Target-matched increased fidelity SpCas9 variants can edit any target without genome-wide off-target effects
Péter István Kulcsár, András Tálas, … Ervin Welker·bioRxiv·Aug 16, 2022
- Basis for discrimination by engineered CRISPR/Cas9 enzymes
M.-S. Liu, S. Gong, … D. W. Taylor·bioRxiv·May 8, 2019
- High-throughput in vitro specificity profiling of natural and high-fidelity CRISPR-Cas9 variants
K. Murugan, A. S. Seetharam, … D. G. Sashital·bioRxiv·May 12, 2020